Trial Profile
A Multi-Center, Randomized, Blinded, Parallel-Group Study of AVONEX Compared With AVONEX in Combination With Oral Methotrexate, Intravenous Methylprednisolone, or Both in Subjects With Relapsing Remitting MS Who Have Breakthrough Disease on AVONEX Monotherapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jun 2015
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Methotrexate; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms ACT
- Sponsors Biogen
- 10 Feb 2009 Results published in Neurology.
- 05 May 2007 Initial results were reported at AAN 2007.
- 05 May 2007 Status changed from in progress to completed.